Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
A method of delivering an oligonucleotide or a plasmid expressing an oligonucleotide into a target cell comprises introducing an oligonucleotide into a donor cell, particularly a stem cell, and contacting the target cell with the donor cell under conditions permitting the donor cell to form a gap junction with the target cell, whereby the oligonucleotide or a product of the oligonucleotide is delivered into the target cell from the donor cell.
1. A method of delivering an oligonucleotide into a target cell comprising:
a) introducing the oligonucleotide or a plasmid expressing the oligonucleotide into a donor cell; and
b) contacting the target cell with the donor cell under conditions permitting the donor cell to form a gap junction channel composed of connexin 40 with the target cell, whereby the oligonucleotide is delivered into the target cell from the donor cell by traversing the gap junction and wherein the oligonucleotide is 12-24 nucleotides in length.
2. The method of claim 1 , wherein the oligonucleotide is RNA that can traverse the gap junction.
3. The method of claim 1 , wherein the oligonucleotide is DNA.
4. The method of claim 1 , wherein the oligonucleotide is an antisense oligonucleotide.
5. The method of claim 1 , wherein the oligonucleotide is an siRNA.
6. The method of claim 1 , wherein the oligonucleotide is a DNA or RNA.
7. The method of claim 1 , wherein the plasmid encodes siRNA.
8. The method of claim 1 , wherein the oligonucleotide is 18-22 nucleotides in length.
9. The method of claim 1 , wherein the donor cell is a human mesenchymal stem cell.
10. The method of claim 1 , wherein the donor cell is a cell containing, or engineered to contain connexin 40.
11. The method of claim 1 , wherein the target cell is present in a syncytial tissue.
12. The method of claim 11 , wherein the cell in the syncytial tissue is selected from the group consisting of a cardiac myocyte, a smooth muscle cell, an epithelial cell, a connective tissue cell, and a syncytial cancer cell.
13. The method of claim 1 , wherein the target call is a white blood cell.
14. The method of claim 1 , wherein the gap junction channel further comprises a second connexin selected from the group consisting of connexin 43 connexin 45, and connexin 37.
15. A method of delivering an oligonucleotide into a target cell comprising:
a) introducing the oligonucleotide into a human mesenchymal stem cell or other donor cell; and
b) contacting the target cell with the human mesenchymal stem cell or other donor cell under conditions permitting the donor cell to form a gap junction channel composed of connexin 40 with the target cell, whereby the oligonucleotide is delivered into the target cell from the donor cell by traversing the gap junction and wherein the oligonucleotide is 12-24 nucleotides in length.
16. A method of delivering an oligonucleotide into a syncytial target cell comprising:
a) introducing the oligonucleotide into a donor cell in vitro; and
b) contacting the syncytial target cell with the donor cell under conditions permitting the donor cell to form a gap junction channel with the syncytial target cell, whereby the oligonucleotide is delivered into the syncytial target cell from the donor cell by traversing the gap junction wherein the gap junction is composed of connexin 40 and wherein the oligonucleotide is 12-24 nucleotides in length.
17. A method of delivering RNA into a target cell comprising:
a) introducing RNA or a plasmid transcribable into RNA into a donor cell in vitro; and
b) contacting the target cell with the donor cell under conditions “permitting the donor cell to form a gap junction channel composed of connexin 40 with the target cell”, whereby the RNA is delivered into the target cell from the donor cell by traversing the gap junction and wherein the RNA is 12-24 nucleotides in length.
18. A method of delivering DNA into a target cell comprising:
a) introducing a DNA or a plasmid coding for the DNA into a donor cell in vitro; and
b) contacting the target cell with the donor cell under conditions “permitting the donor cell to form a gap junction channel composed of connexin 40 with the target cell”, whereby the DNA is delivered into the target cell from the donor cell by traversing the gap junction and wherein the DNA is 12-24 nucleotides in length.
19. The method of claim 15 , wherein the donor cell is a human mesenchymal stem cell.
20. The method of claim 16 , wherein the donor cell is a human mesenchymal stem cell.
21. The method of claim 17 , wherein the donor cell is a human mesenchymal stem cell.
22. The method of claim 18 , wherein the donor cell is a human mesenchymal stem cell.